Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Testicular Cancer: A Second Chance

New Treatment Strategy Uses Stem Cells Combined With High-Dose Chemo After Preferred Treatment Fails

Testicular Cancer 'Eminently Curable' continued...

Abonour says that this dilemma is resolved, unless patients have other conditions that make it impossible for them to tolerate intensive chemotherapy. He suggests that all testicular cancer patients who fail preferred treatment are candidates for the new technique.

That's true, agrees Edmund K. Waller, MD, PhD, director of the bone marrow and transplant center at Emory Winship Cancer Institute in Atlanta.

"The potential to cure patients after they fail standard therapy without transplant is somewhat limited," Waller tells WebMD. "If they have second-line therapy that is not curative, the chances for third-line success is less."

Kohli, Waller, and Abonour say the excellent outcomes seen in the Indiana study can only be achieved in cancer centers that can field teams of experts able to provide intensive patient support.

"High-dose chemotherapy with stem cell support is not done in community hospitals, but typically at a referral center," Waller says.

"Families really should ask the important question: Is the oncology team familiar with the disease?" Abonour says. "It takes an experienced team to work together to identify the right patients and the right treatment for each of them."

The study by Einhorn, Abonour, and colleagues appears in the July 26 issue of The New England Journal of Medicine.


Today on WebMD

Building a Support System
cancer fighting foods
precancerous lesions slideshow
quit smoking tips
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas